News
Manitoulin's whitetail rifle hunt features unchanged antlerless quotas of 400 (WMU 43A) and 6,100 (WMU 43B), with the MNR reminding hunters to follow safety, tagging, and property rules.
As Ontario’s medical regulator pauses new prescribing requirements, a drug poisoning warning and a push to put naloxone beside defibrillators highlight the stakes for Sudbury and Manitoulin.
SUDBURY—Public Health Sudbury and Districts warned on November 5 of a rise in drug poisonings and unexpected reactions across the Sudbury and Manitoulin districts. People experienced heavy sedation, confusion and memory loss. The cause of the increase remains unknown, but public health officials warned that unregulated drugs can contain fentanyl, carfentanil or sedatives such as benzodiazepines, xylazine and medetomidine.
The warning came as new figures from Ontario’s coroner showed that 36 people died of opioid toxicity in Greater Sudbury in the first six months of 2026. At 38.20 deaths per 100,000 residents, the city’s rate was more than four times the provincial rate of 9.47 per 100,000. Greater Sudbury ranked third in Ontario, behind Thunder Bay and Sarnia, up from fourth in 2025. The deaths occurred before Ontario’s medical regulator approved new rules for prescribing safer supply.
The unregulated drug supply can contain powerful synthetic opioids and sedatives that people may consume without knowing. Across Greater Sudbury, Manitoulin Island and the North Shore, that uncertainty compounds the challenges of getting care. Long distances, limited transportation and a strained health care system can make treatment difficult to reach. Housing insecurity, poverty, chronic pain and trauma can make it harder to get and stay connected to care.
Subscribe now and have access to all our stories, enjoy exclusive content and stay up to date with constant updates.
Already a member? Sign in